No CrossRef data available.
Article contents
A Public Option for Clinical Trials? Lessons from Convalescent Plasma
Published online by Cambridge University Press: 31 May 2024
Abstract
The case of clinical trials for convalescent plasma during COVID-19 illustrates important lessons for realizing public sector approaches to biomedical research and development. These lessons, centering on mission, transparency, and spillover effects, can be translated to wider efforts to develop a “public option” for clinical trials.
Keywords
- Type
- Commentary
- Information
- Copyright
- © The Author(s), 2024. Published by Cambridge University Press on behalf of American Society of Law, Medicine & Ethics